Substance-Related and Addictive Disorders Flashcards
Inhalant Use Disorder
A. A problematic pattern of use of a hydrocarbon-based inhalant substance leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period:
Specify if:
the particular inhalant:
When possible, the particular substance involved should be named (e.g., “solvent use disorder”):
Opioid Use Disorder
A problematic pattern of opioid use leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period:
Opioid Use Disorder
Withdrawal
Note:
This criterion is not considered to be met for those individuals taking opioids solely under appropriate medical supervision.
a. The characteristic opioid withdrawal syndrome
b. Opioids (or a closely related substance) are taken to relieve or avoid withdrawal symptoms
Opioid Use Disorder
On maintenance therapy
This additional specifier is used if the individual is taking a prescribed agonist medication such as methadone or buprenorphine and none of the criteria for opioid use disorder have been met for that class of medication (except tolerance to, or withdrawal from, the agonist.) This category also applies to those individuals being maintained on a partial agonist, an agonist/antagonist, or a full antagonist such as oral naltrexone or depot naltrexone.
DSM-5 Substance Use Disorder
A problematic pattern of substance use leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period:
1.
The substance is often taken in larger amounts or over a longer period than was intended.
2.
There is a persistent desire or unsuccessful efforts to cut down or control use of the substance.
3.
A great deal of time is spent in activities necessary to obtain the substance, use it, or recover from its effects.
4.
Craving, or a strong desire or urge to use the substance.
5.
Recurrent use of the substance resulting in a failure to fulfil major role obligations at work, school, or home.
6.
Continued use of the substance despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of its use.
7.
Important social, occupational, or recreational activities are given up or reduced because of the use of the substance.
8.
Recurrent use of the substance in situations in which it is physically hazardous.
9.
Use of the substance is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance.
10.
- Tolerance, as defined by either of the following:
a. A need for markedly increased amounts of the inhalant substance to achieve intoxication or desired effects.
b. A markedly diminished effect with the continued use of the same amount of the inhalant substance.
11.
Withdrawal, as manifested by either of the following:
a. The characteristic withdrawal syndrome for the substance (refer to criteria A and B of the criteria sets for Withdrawal from the specific substances)
b. the same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms.